GT Biopharma to Participate In-Person at 34th Annual ROTH Conference, March 13-15, 2022
BRISBANE, Calif., March 3, 2022 /PRNewswire/ -- GT Biopharma, Inc. , a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary... | March 3, 2022